Bologna, Italy

Andrea Cavalli

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 6.5

ph-index = 1


Location History:

  • San Lazzaro di Savena, IT (2009)
  • Genoa, IT (2017)
  • S. Lazzaro di Savena, IT (2017)
  • Bologna, IT (2018)

Company Filing History:


Years Active: 2009-2018

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Andrea Cavalli: Innovator in Neurodegenerative Disorder Treatments

Introduction

Andrea Cavalli is a prominent inventor based in Bologna, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative disorders. With a total of four patents to her name, Cavalli's work focuses on innovative compounds that aim to improve cognitive health.

Latest Patents

Cavalli's latest patents include groundbreaking inventions such as dual inhibitor compounds for use in the treatment of neurodegenerative disorders and Alzheimer's disease. This invention relates to compounds of Formula (I) and pharmaceutical compositions that can be utilized in the prevention or treatment of central nervous system diseases, particularly cognitive and neurodegenerative disorders. Another notable patent involves phenyl carbamates, which serve as inhibitors of the fatty acid amide hydrolase (FAAH) enzyme and modulators of the D3 dopamine receptor (D3DR). This invention also provides compounds of Formula (I) or pharmaceutically acceptable salts thereof.

Career Highlights

Throughout her career, Cavalli has worked with esteemed organizations such as the Fondazione Istituto Italiano di Tecnologia and Alma Mater Studiorum - Università di Bologna. Her work in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Cavalli has collaborated with notable colleagues, including Giovanni Bottegoni and Angelo Danilo Favia. These partnerships have enriched her research and fostered innovation in her field.

Conclusion

Andrea Cavalli is a trailblazer in the development of treatments for neurodegenerative disorders. Her innovative patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…